Cargando…
Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature
Mitotane has been used for more than 5 decades as therapy for adrenocortical carcinoma (ACC). However its mechanism of action and the extent of tumor response remain incompletely understood. To date no cases of rapid and complete remission of metastatic ACC with mitotane monotherapy has been reporte...
Autores principales: | Ghorayeb, Nada El, Rondeau, Geneviève, Latour, Mathieu, Cohade, Christian, Olney, Harold, Lacroix, André, Perrotte, Paul, Sabourin, Alexis, Mazzuco, Tania L, Bourdeau, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998541/ https://www.ncbi.nlm.nih.gov/pubmed/27043680 http://dx.doi.org/10.1097/MD.0000000000003180 |
Ejemplares similares
-
First case report of an adrenocortical carcinoma caused by a BRCA2 mutation
por: El Ghorayeb, Nada, et al.
Publicado: (2016) -
Characterization of hyperlipidemia secondary to mitotane in adrenocortical carcinoma
por: Gagnon, Nadia, et al.
Publicado: (2022) -
Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding
por: Younes, Nada, et al.
Publicado: (2021) -
Recovery of Adrenal Insufficiency Is Frequent After Adjuvant Mitotane Therapy in Patients with Adrenocortical Carcinoma
por: Poirier, Jonathan, et al.
Publicado: (2020) -
SAT-158 New Data on High Prevalence and Time of Occurrence of New Onset Hypothyroidism Associated with Mitotane Therapy in a Cohort of Adrenocortical Cancer
por: Poirier, Jonathan, et al.
Publicado: (2020)